Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for AVICHINA?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2016–2025
Financial statements are reported in CNY, while share price and market cap are quoted in HKD.
Key Multi-Year Facts
- Revenue moved from CN¥36.83B in FY2016 to CN¥89.44B in FY2025 (9-year CAGR +10.4%).
- Profitable in every fiscal year across 2016–2025.
- Operating cash flow was below half of net income in FY2016, FY2018, FY2020, FY2023, FY2025.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (CNY B) | 60.3 | 78.8 | 84.8 | 87.0 | 89.4 |
| YoY | 18.4% | 30.6% | 7.6% | 2.6% | 2.8% |
| Net Income (CNY B) | 2.37 | 2.32 | 2.45 | 2.19 | 1.77 |
| YoY | 22.6% | -2.1% | 5.5% | -10.6% | -19.3% |
| Operating Cash Flow (CNY B) | 2.24 | 10.2 | -4.08 | 2.17 | -8.12 |
| ROE | 9.5% | 8.2% | 8.0% | 6.7% | 5.1% |
| Gross Margin | 21.1% | 23.9% | 25.0% | 21.7% | 19.5% |
| Net Margin | 3.9% | 2.9% | 2.9% | 2.5% | 2.0% |
| Debt-to-Assets | 59.1% | 57.8% | 52.4% | 52.2% | 51.8% |
Show all 10 fiscal years
| Fiscal Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (CNY B) | 36.8 | 32.6 | 35.8 | 43.8 | 50.9 | 60.3 | 78.8 | 84.8 | 87.0 | 89.4 |
| YoY | — | -11.5% | 9.7% | 22.6% | 16.2% | 18.4% | 30.6% | 7.6% | 2.6% | 2.8% |
| Net Income (CNY B) | 1.16 | 1.22 | 1.29 | 1.35 | 1.93 | 2.37 | 2.32 | 2.45 | 2.19 | 1.77 |
| YoY | — | 5.4% | 5.2% | 4.8% | 43.5% | 22.6% | -2.1% | 5.5% | -10.6% | -19.3% |
| Operating Cash Flow (CNY B) | -0.93 | 1.59 | 0.55 | 5.38 | 0.86 | 2.24 | 10.2 | -4.08 | 2.17 | -8.12 |
| ROE | — | 8.3% | 7.9% | 7.0% | 8.9% | 9.5% | 8.2% | 8.0% | 6.7% | 5.1% |
| Gross Margin | 19.1% | 22.8% | 21.8% | 22.0% | 20.5% | 21.1% | 23.9% | 25.0% | 21.7% | 19.5% |
| Net Margin | 3.1% | 3.7% | 3.6% | 3.1% | 3.8% | 3.9% | 2.9% | 2.9% | 2.5% | 2.0% |
| Debt-to-Assets | — | — | 64.0% | 63.0% | 60.1% | 59.1% | 57.8% | 52.4% | 52.2% | 51.8% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-05
Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).
Items Flagged for Review
-
Alert
Cash ConversionFinancial Quality
OCF / Net Income: FY2025 (2025-12-31) -4.60, FY2024 (2024-12-31) 0.99
FY2025 (ended 2025-12-31) · What is this?
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
Dividends
Trailing 12-month dividend: HK$0.076 per share, or 2.50% yield at closing price; last full fiscal year: HK$0.076 (payout ratio 34.4%).
Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.
More data: All research reports · Sector leaders · Market hours & holidays.
Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.